Rocket Lab (RKLB) Stock: SVP Sells $9.5M as Insider Sales Mount — Should You Be Worried?

TLDR

• Rocket Lab SVP Arjun Kampani sold 88,000 RKLB shares on June 18 at $107.98, totaling ~$9.5 million.
• The sale reduced Kampani’s stake by 24.95%; he still holds 264,705 shares worth ~$28.6 million.
• RKLB traded down to $107.24 on heavy volume — nearly triple its average daily volume.
• Rocket Lab posted 63.4% year-over-year revenue growth in Q1 and beat analyst estimates.
• The stock is set to join the Nasdaq-100 on June 22, which could drive passive fund buying.

Rocket Lab (RKLB) SVP and General Counsel Arjun Kampani sold 88,000 shares on June 18 at an average price of $107.98, pulling in approximately $9.5 million from the transaction.

Rocket Lab USA, Inc., RKLB

Following the sale, Kampani still directly owns 264,705 shares, valued at roughly $28.6 million. The transaction represents a 24.95% reduction in his personal stake.

This wasn’t a one-off move. Kampani has been selling steadily — he offloaded 28,668 shares on May 26 at $142.57, then 70,000 on May 27 at $145.13, and another 23,804 on May 28 at $147.43.

Over the past year, he has sold a total of 342,714 shares. There have been zero insider purchases recorded during that same period, and 43 insider sales in total across the company.

RKLB stock fell $0.74 on the day, closing at $107.24. Volume hit 70.2 million shares — nearly three times the average daily volume of 24.8 million.

Stock Still Well Above Long-Term Average

Despite the pullback, RKLB is trading well above its 200-day moving average of $82.68 and its 50-day average of $104.00. The stock’s 52-week range runs from a low of $27.84 to a high of $151.00.

The market cap stands at $62.07 billion. The price-to-earnings ratio sits at -335.12, reflecting the company is not yet profitable. The beta is 2.49, meaning the stock moves sharply relative to the broader market.

Analysts put the average consensus price target at $102.76, with a “Moderate Buy” rating. Price targets range from $105 (KGI Securities, neutral) to $150 (New Street Research, buy). Stifel Nicolaus has a $132 target; KeyCorp recently upgraded the stock to overweight with a $135 target.

Strong Fundamentals, Valuation Questions Remain

In its most recent earnings report on May 7, Rocket Lab posted revenue of $200.35 million, beating analyst estimates of $189.65 million by roughly $10.7 million.

Revenue was up 63.4% year-over-year. EPS came in at -$0.07, matching consensus. The company carries a $2.2 billion backlog.

Rocket Lab also recently cleared a key Space Development Agency review, strengthening its defense program credentials.

Starting June 22, RKLB will be added to the Nasdaq-100 index. That inclusion typically triggers passive buying from index funds and ETFs that track the index.

Institutional ownership currently sits at 71.78%. Vanguard holds 47.4 million shares, Baillie Gifford owns 17.9 million, and Capital World Investors holds 16.2 million.

GuruFocus estimates the stock’s intrinsic value at $26.42, putting its price-to-GF-Value ratio at 4.09 — a level it flags as overvalued.

Sell-side analysts project full-year EPS of -$0.29 for the current fiscal year.

The post Rocket Lab (RKLB) Stock: SVP Sells $9.5M as Insider Sales Mount — Should You Be Worried? appeared first on CoinCentral.